newmarket-strategy.comCrawled Nov 8, 2026
Newmarket Strategy provides expertise in market access, global health policy, government affairs, and health economics.
Shaping health policy and government engagement to help life sciences and healthcare innovations navigate the system and reach patients at scale.
Generating and communicating the evidence that drives reimbursement, access and healthcare decision-making, powered by Visible Analytics.
Strategic market access support — from pipeline reviews and launch strategy to HTA submission and commercial negotiation — to secure lasting access.
Newmarket Strategy collaborates with NHS organizations, partners, and suppliers on addressing elective recovery challenges.
The Brexit trade deal is significant due to the close economic ties between the EU and the UK, with monthly trade involving at least 45 million packs of medicines.
How Newmarket Strategy helps healthcare and life sciences clients secure access, shape policy and build the evidence behind their innovations.
Newmarket Strategy, a specialist healthcare and life sciences consultancy, announces today the successful acquisition of Visible Analytics, experts in Health Economics and Outcomes Research (HEOR) and data analytics.
Newmarket Strategy has appointed Robert Kettell, the NHS’s Director of Medicines Negotiation, to its leadership team.
Newmarket Strategy’s team includes specialists in market access, health policy, and health economics, focusing on accelerating innovations to patients.
Newmarket Strategy offers consultancy in market access, health policy, and evidence strategy for healthcare and life sciences innovations.
Newmarket Strategy is a market access consultancy offering strategic advice and technical support to healthcare and life sciences organizations.
Copyright 2021-2026 Newmarket Strategy Ltd. All rights reserved.